The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in HFrEF.
Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...
Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the ...
Compounded GLP-1 medications help fill a necessary gap, but can have significant safety issues. Compounded GLP-1 medications are largely unregulated and may contain contaminated ingredients. Stronger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results